Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−61.09 MUSD
80.82 MUSD
2.63 M
About LakeShore Biopharma Co., Ltd
Sector
Industry
CEO
Xu Wang
Website
Headquarters
Beijing
Founded
2020
FIGI
BBG00ZKXZ446
LakeShore Biopharma Co., Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LSB is 3.13 USD — it has decreased by −0.35% in the past 24 hours. Watch LakeShore Biopharma Co., Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange LakeShore Biopharma Co., Ltd stocks are traded under the ticker LSB.
LSB stock has fallen by −5.47% compared to the previous week, the month change is a −60.89% fall, over the last year LakeShore Biopharma Co., Ltd has showed a −27.29% decrease.
LSB stock is 42.31% volatile and has beta coefficient of 2.39. Track LakeShore Biopharma Co., Ltd stock price on the chart and check out the list of the most volatile stocks — is LakeShore Biopharma Co., Ltd there?
Today LakeShore Biopharma Co., Ltd has the market capitalization of 59.70 M, it has decreased by −16.89% over the last week.
Yes, you can track LakeShore Biopharma Co., Ltd financials in yearly and quarterly reports right on TradingView.
LakeShore Biopharma Co., Ltd is going to release the next earnings report on Jan 27, 2025. Keep track of upcoming events with our Earnings Calendar.
LSB earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.94 USD resulting in a 90.00% surprise. The estimated earnings for the next quarter are −0.78 USD per share. See more details about LakeShore Biopharma Co., Ltd earnings.
LakeShore Biopharma Co., Ltd revenue for the last quarter amounts to 24.19 M USD, despite the estimated figure of 24.19 M USD. In the next quarter, revenue is expected to reach 26.40 M USD.
LSB net income for the last quarter is −25.47 M USD, while the quarter before that showed −11.31 M USD of net income which accounts for −125.13% change. Track more LakeShore Biopharma Co., Ltd financial stats to get the full picture.
No, LSB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 27, 2024, the company has 758.00 employees. See our rating of the largest employees — is LakeShore Biopharma Co., Ltd on this list?
Like other stocks, LSB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LakeShore Biopharma Co., Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LakeShore Biopharma Co., Ltd technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LakeShore Biopharma Co., Ltd stock shows the strong sell signal. See more of LakeShore Biopharma Co., Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.